Agilon Health Q3 revenue beats estimates, raises FY guidance

agilon health

04/11/2026 22:16

Overview
U.S. value-based care platform's Q3 revenue rose 6%, beating analyst expectations
Net income turned positive in Q3, beating analyst estimates
Adjusted EBITDA for Q3 rose, driven by improved pricing and payor contracting

Outlook
Company raises 2026 revenue guidance to $5.87 bln-$5.89 bln from $5.78 bln-$5.86 bln
Company lifts 2026 adjusted EBITDA outlook to $145 mln-$155 mln from $75 mln-$95 mln
Company expects 2026 medical services expense ratio of 90.5%-90.3%, improved from 91.9%-91.4% prior

Result Drivers
MEMBERSHIP DECLINE - Co said total members on platform fell 8% YoY due to disciplined contracting, market exits and measured growth approach
REVENUE DRIVERS - Revenue rose due to higher-than-expected burden of illness performance, payor contracting, and improved pricing, partly offset by lower membership
LOWER MEDICAL COSTS - Medical services expense ratio improved to 88.5% from 104.0%, reflecting favorable claims development

Company press release: ID:nBw6j2KQfa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$1.52 bln
$1.46 bln (14 Analysts)
Q3 Net Income
Beat
$35 mln
-$21.005 mln (9 Analysts)
Q3 Adjusted EBITDA
Beat
$64 mln
$506,690 (13 Analysts)

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy", 9 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for agilon health, inc. is $115.00, about 31% above its November 3 closing price of $87.79

Reuters Recommended Reads
Nov 4 - Health insurers, hospitals rally after sweeping midterm win for Democrats 
Nov 3 - Senior care provider InnovAge's Q1 revenue beats as participants increase
Nov 2 - Hinge Health Q3 revenue jumps 52%, beats estimates

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)